What is the starting dose for Crestor (rosuvastatin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose for Rosuvastatin (Crestor)

The recommended starting dose for rosuvastatin (Crestor) is 10 mg once daily for most patients, with a dosage range of 5-40 mg daily depending on patient factors and treatment goals. 1

Standard Dosing Recommendations

  • Initial dose: 10-20 mg once daily for standard therapy 2
  • Dose range: 5-40 mg once daily 1
  • Administration: Can be taken with or without food, at any time of day 1

Dose Adjustments Based on Patient Factors

Special Populations

  • Asian patients: Start with 5 mg once daily 1
  • Patients with severe renal impairment (CrCl <30 mL/min):
    • Start with 5 mg once daily
    • Maximum dose should not exceed 10 mg daily 2, 1

Drug Interactions

  • Patients taking cyclosporine, tacrolimus, everolimus, or sirolimus:
    • Maximum dose should be limited to 5 mg daily due to severe drug interactions
    • These immunosuppressants can increase rosuvastatin exposure 7-fold 3, 2

Dosing Based on Treatment Intensity

Intensity Level LDL-C Reduction Rosuvastatin Dose
High-Intensity ≥50% 20-40 mg daily
Moderate-Intensity 30-49% 5-10 mg daily

Monitoring and Dose Titration

  • Assess LDL-C response as early as 4 weeks after initiating therapy 1
  • Adjust dosage if necessary based on lipid response and treatment goals
  • For high-risk patients requiring >50% LDL-C reduction, consider starting with or titrating to 20-40 mg daily 2

Clinical Efficacy

Rosuvastatin demonstrates greater LDL-C reduction compared to other statins at equivalent doses:

  • 10 mg rosuvastatin reduces LDL-C by approximately 49% 4
  • This is significantly more effective than pravastatin 20 mg (28% reduction) and simvastatin 20 mg (37% reduction) 4

Safety Considerations

  • Most common adverse events are mild to moderate: myalgia, constipation, asthenia, abdominal pain, and nausea 5
  • Monitor for muscle symptoms, as with all statins
  • Do not exceed 40 mg daily as this is considered the maximum therapeutic dose 2

Rosuvastatin's favorable pharmacologic profile includes selective uptake by hepatic cells and hydrophilic nature, contributing to its efficacy and safety profile 5.

References

Guideline

Statin Therapy for Hyperlipidemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rosuvastatin: a review of its use in the management of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.